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Abstract 
Di(2-ethylhexyl) phthalate (DEHP) is a known chiral persistent organic pollutant found in many 
different consumer products, and the toxicities of its stereoisomers and their metabolites are not 
well known. To determine their adverse health effects, each enantiomer has to be synthesized. 
Using lipase PS from Burkholderia cepacia in dichloromethane at 0˚C for 48 hours, 2-ethyl-1-
hexyl acetate was obtained in 55% yield (75:25 e.r.), while (R)-2-ethyl-1-hexanol (1) was 
obtained in 29% yield (96:4 e.r.).  The acetate was then hydrolyzed to recover the (S) enriched 
alcohol (82% yield). The enriched alcohol was acylated a second time to yield (S)-(1) in 39% 
yield (91:9 e.r.). R-(1) and phthalic anhydride were reacted in 1:3 pyridine/toluene at 100˚C for 2 
hours to synthesize (R)-mono(2-ethylhexyl) phthalate ((R)-MEHP) in 50% yield. Difficulty was 
encountered in separating MEHP from (1) in the reaction mixture, with numerous solvent 
systems, vacuum distillation, and chemically active extraction attempted without success. The 
resulting impure (R)-MEHP was reacted with (R)-(1) in the presence of N,N’-
diisopropylcarbodiimide and 4-dimethylaminopyridine in dichloromethane for 19 hours at room 
temperature to synthesize(R,R)- DEHP in 36% yield. Future work will synthesize the other 
isomers of DEHP, further purify (1), and successfully separate MEHP from (1). 
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Introduction 
 Di(2-ethylhexyl) phthalate (or DEHP) is a compound used industrially as a plasticizer for 
polyvinyl chloride (PVC) (Scheme 1). In this application, it can be found in many common 
products, such as blood bags and other medical equipment, toys, and vinyl flooring.1 In addition, 
DEHP and other phthalates are a common additive to products ranging from oils and lubricants 
to cosmetics. Industrial production of DEHP for these applications exceeds 2 million tons per 
year.2 Due to this widespread usage and production, DEHP is a common environmental 
contaminant. Human exposure to DEHP is mainly thought to occur through ingestion, with 
leaching from plastic containers, food wrappers and inhalation of contaminated dust being the 
predominant pathways. Other exposure routes include intravenous exposure through blood and 
other medical bags, dermal contact with contaminated surfaces, and transfer between mother 
and fetus during pregnancy.3,4 
 Previous research has shown that DEHP and other phthalates are endocrine disruptors,5 
with exposure to phthalates causing developmental and reproductive abnormalities in laboratory 
animals. Some of these effects include reduced sperm production in zebra fish,6 decreased 
estradiol levels and growth of antral follicles cultured from mice,7 reduced fertility and birth 
defects in rats,8 and testicular abnormalities in rodents1. Studies in human populations have 
also correlated high levels of phthalates with abnormal reproduction and development. These 
include decreased masculine behavior in male children,9 reduced anogenital distance in male 
newborns,10 and reduced fertility.11  
 Upon ingestion, DEHP is hydrolyzed to form mono(2-ethylhexyl) phthalate (MEHP), 
which is subsequently oxidized to form several metabolites (Scheme 1). The oxidation of MEHP 
is accomplished in the liver by the cytochrome P450 (CYP) family of enzymes. These heme 
containing enzymes use molecular oxygen to oxidize a wide range of compounds, including 
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fatty acids, sterols, and therapeutic drugs. Indeed, it is estimated that CYP enzymes are 
responsible for metabolizing 75% of the drugs on the market.12 The purpose of this oxidation is 
to increase the polarity of these molecules so that they are more soluble in water, allowing them 
to be excreted in urine. The effect of this oxidation is highly variable. For many compounds, 
metabolism by CYP enzymes renders them inactive. On the other hand, some are rendered 
more potent. Notable examples of this are prodrugs, which are ingested in an inactive form but 
are metabolized into their therapeutic form.13 This dichotomy is not just limited to therapeutic 
drugs but is also seen in toxic compounds. 
  Some of the oxidative metabolites produced by CYP enzymes that have been detected 
in urine and blood serum are mono(2-ethyl-6-hydroxyhexyl) phthalate (6-OH –MEHP), mono(2-
ethyl-5-hydroxyhexyl) phthalate (5-OH-MEHP), mono(2-ethyl-5-oxyethyl) phthalate (5-oxo-
MEHP), and mono(2-ethyl-5-carboxypentyl) phthalate (5-carboxy-MEPP) (Scheme 1). 5,14 Some 
of these metabolic products are thought to be more toxic than DEHP itself, with MEHP causing 
higher fetal mortality and abnormalities in mice than DEHP.8 The toxicity of DEHP has been 
attributed to both estrogen receptor and peroxisomal proliferator-activated receptor (PPAR) 
activation. Considerable research has been devoted to determining the relative contributions of 
each pathway to the toxicity of DEHP.15,16 Both PPAR and estrogen receptors are nuclear 
receptors, meaning that they are associated with nuclear DNA and regulate gene expression at 
the transcriptional level. The estrogen receptor mainly regulates genes associated with sexual 
development and reproduction, but also regulates such disparate processes as lipid metabolism 
and glucose uptake.17 PPARs as a class are mainly involved in lipid metabolism, but like 
estrogen have disparate roles in inflammation and fertility.18 
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In recent years, the chirality of environmental pollutants has become an important avenue of 
research. Biological systems are inherently sensitive to changes in three dimensional 
configuration, and the change of a single chiral center can affect the biological activity of a 
compound. A classic example of this phenomenon is the drug thalidomide, a sedative and 
antiemetic sold from 1957 to 1961. Due to its effectiveness in treating nausea, the drug was 
widely prescribed to treat morning sickness in pregnant women. It was discovered that taking 
thalidomide during pregnancy caused abnormal limb development in fetuses. Thalidomide 
contains a single chiral center and was sold as a racemic mixture. The R enantiomer was an 
effective morning sickness treatment, while the S enantiomer caused birth defects.19 Other 
examples include pyrethroid insecticides, organophosphate pesticides, and some 
polychlorinated biphenyls (PCB’s). These three classes of compounds are chiral and have very 
different environmental fates and biological activity that are dependent upon stereochemistry.20  
Scheme 1: Metabolism of DEHP and the resulting oxidative metabolites  
(Reproduced courtesy of Kelly McDaniel) 
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 Industrially synthesized DEHP contains three different stereoisomers, (R,R)-DEHP,    
(R,S)-DEHP, and (S,S)-DEHP. Both (R,R)-DEHP and (S,S)-DEHP are chiral molecules, while 
(R,S)-DEHP is a meso compound. In addition, each DEHP metabolite mentioned above has at 
least two stereoisomers. Due to the different spatial configuration of these isomers, it is likely 
that they have different binding affinities for PPAR and estrogen receptors and thus vary in their 
toxicity. Moreover, the relative rates of metabolism between the different stereoisomers of 
MEHP and its metabolites by cytochrome P450 enzymes are also unknown, meaning that their 
retention in the body could vary. However, measuring receptor binding and enzyme metabolism 
would be difficult using the racemic mixtures of DEHP and its metabolites. In an achiral 
environment, enantiomers have the same physical and chemical properties under most 
conditions. Thus, a method for synthesizing enantiomerically pure samples of these compounds 
is needed.  
 DEHP is industrially produced via an esterification reaction between one equivalent of 
phthalic anhydride and two equivalents of 2-ethyl-1-hexanol (Scheme 2). Since the two chiral 
centers of DEHP are introduced via the two 2-ethyl-1-hexyl chains, resolution of 2-ethyl-1-
hexanol and then a stepwise reaction of two equivalents of enantiomerically pure 2-ethyl-1-
hexanol would produce a single stereoisomer of DEHP with a known configuration. 
 
  
 
Scheme 2: Synthesis of DEHP from 2-ethyl-1-hexanol and phthalic anhydride. The two chiral centers 
present in DEHP are introduced through the 2-ethylhexyl moieties, meaning that the stereoisomers of 
DEHP can be synthesized using enantiomerically pure samples of 2-ethyl1-hexanol.  
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Numerous methods exist for preparing enantiomerically pure samples of primary alcohols. One 
strategy involves utilizing stereoselective reactions such as the Evans21,22 and Meyers23 
alkylations. However, these methods have several drawbacks. Syntheses tend to be multistep, 
more challenging, and require each enantiomer to be synthesized independently. A second 
method utilizes biologically derived enzymes to kinetically resolve a racemic mixture of 2-ethyl-
1-hexanol. This method takes advantage of the stereoselectivity inherent to most biological 
systems. By lowering the activation energy required to react one of the enantiomers, one 
enantiomer is chemically modified, leaving the other enantiomer unreacted. This method is 
particularly attractive because it allows both enantiomers of 2-ethyl-1-hexanol to be isolated 
simultaneously. 
 Of particular importance here is the work of Chantal and Krystyna,24 who used a lipase 
isolated from the bacterial species Burkholderia cepacia (PSBC) to resolve 2-ethyl-1-hexanol in 
high enantiomeric purity. The enzyme was used to transfer an acyl group from vinyl acetate to 
(S)-2-ethyl-1-hexanol, leaving behind (R)-2-ethyl-1-hexanol. Purification by column 
chromatography allows the (R) alcohol and (S) acetate to be separated, with recovery of the (S) 
acetate only requiring a simple hydrolysis reaction under basic conditions. By varying the 
solvent, temperature, and reaction time, the researchers were able to maximize the 
enantiomeric purity of the two enantiomers. Two rounds of acylation and hydrolysis were 
required to recover the (S) alcohol in high enantiomeric purity. The reactions used by the 
researchers are summarized in Scheme 3. 
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 Once resolved, these samples can be used to synthesize MEHP and DEHP of a known 
configuration. Reacting one equivalent of phthalic anhydride with 2-ethyl-1-hexanol yields 
MEHP, which can then be reacted with a second equivalent of 2-ethyl-1-hexanol to produce 
DEHP. Because the synthesis of DEHP requires the two equivalents of 2-ethyl-1-hexanol to be 
added stepwise, the configuration of the resulting molecule can be easily controlled. The 
reactions used to synthesize MEHP and DEHP are shown in Scheme 4, with the synthesis of 
(R)-MEHP and (R,R)-DEHP shown specifically. 
Scheme 3: Enzymatic resolution of 2-ethyl-1-hexanol using PSBC 
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 The utility of these reactions are not limited to resolving 2-ethyl-1-hexanol and 
synthesizing MEHP and DEHP. The enzymatic resolution outlined in Scheme 2 and the 
reactions outlined in Scheme 3 could be used with other alcohols, namely 2-ethyl-5-hexen-1-ol 
and 2-allyl-1-hexanol. Enantiomerically pure samples of these alcohols could then be used to 
synthesize chiral versions of several oxidative metabolites of MEHP, such as 6-OH-MEHP, 5-
oxo-MEHP, 5cx-MEPP, and 2cx-MHPP. The reactions necessary to synthesize these 
metabolites from 2-ethyl-5-hexen-1-ol, 2-allyl-1-hexanol and phthalic anhydride are shown in 
Scheme 5.  
Scheme 4: Proposed synthesis of R-MEHP and R,R-DEHP 
 
  13 
 
 
 Once synthesized, the chiral samples of DEHP, MEHP, and the oxidative metabolites 
could be used in a variety of studies. One possibility is to conduct in vivo toxicological studies 
using model organisms, such as mice and zebra fish. In addition, the binding affinity of each 
compound to PPAR can be analyzed using a thermal shift assay. This assay measures binding 
affinity by the increased melting temperature of a protein-ligand complex compared to the free 
protein. During melting, a protein unfolds, exposing its hydrophobic core. When a fluorescent 
dye is present in the solution, this dye associates with the hydrophobic core and fluoresces at a 
higher intensity. This allows the melting temperature of the protein to be determined by 
measuring the fluorescence of the solution. When ligand is bound to the protein, the energy of 
the complex is lower in energy than the unbound protein. This means that the protein-ligand 
complex requires more energy to melt than the unbound protein, corresponding to a higher 
melting temperature. Because binding affinity is a measure of the stability of the protein-ligand 
Scheme 5: Synthesis of MEHP metabolites 
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complex, this allows a direct measure of the binding affinity of PPAR for DEHP, MEHP and the 
oxidative metabolites.25,26 
 In addition, the oxidation of the enantiomers of MEHP by CYP enzymes can also be 
investigated.  Like the lipase used to resolve 2-ethyl-1-hexanol, enzymes in general tend to be 
stereoselective. This means that one enantiomer of MEHP could take longer to be oxidized. 
Because excretion of MEHP depends on its oxidation, one enantiomer could have a longer 
lifetime in the body and exacerbate any toxic effects. In addition, it is possible that CYP 
enzymes will produce different oxidative metabolites from the two enantiomers. To our 
knowledge, no research in this area has been conducted. By incubating CYP enzymes with 
enantiomerically pure MEHP and the required cofactors, the extent of reaction and products 
formed can be measured and quantitated using GC-MS, HPLC or LC-MS.  
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Experimental 
General: All solvents and solutions were used without further purification unless otherwise 
indicated. The manufacturers and grades of all solvents and reagents can be found in the 
appendix. Solutions for NMR spectroscopy were made in deuterated chloroform with 0.1% 
trimethylsilane as a reference and run on a Varian EM360A NMR (60 MHz). Infrared spectra 
were obtained on a Perkin-Elmer RX1 FTIR using neat samples pressed between KBr salt 
plates. All products were purified via flash chromatography on a Biotage Isolera One equipped 
with SNAP Ultra columns. 
Acylation Optimization: Lipases from Pseudomonas flourescens, porcine pancreas, and 
Burkholderia cepacia were screened using 2-ethyl-1-hexanol (0.65 g, 5 mmol) and vinyl acetate 
(1.72 g, 20 mmol, 4 eq) and varying temperatures, solvents and reaction times. To take kinetic 
data, 3-4 drops of the reaction mixture were filtered over Celite packed in a Pasteur pipette and 
washed with approximately 2 mL of dichloromethane. These solutions were then analyzed using 
chiral Gas Chromatography with a flame ionized detector (GC-FID) 
Selective Acylation: 2-ethyl-1-hexanol (2.60 g, 20 mmol), vinyl acetate (6.89 g, 80 mmol, 4 eq), 
and lipase (amano lipase from Burkholderia cepacia, 0.300 g, 15 mg/mmol alcohol) were 
combined in 20 mL dichloromethane and stirred at 0oC for 48 hours. The reaction mixture was 
then filtered over Celite to remove the lipase, and the solvent evaporated under reduced 
pressure. The crude product was then purified via automated flash chromatography on silica in 
an ethyl acetate/hexanes gradient (2-20% ethyl acetate). The fractions were tested by thin layer 
chromatography (1:9 ethyl acetate hexanes, stained with CAM). The fractions were then 
combined and evaporated under reduced pressure to yield (R)-2-ethyl-1-hexanol (29% yield, 
96:4 e:r) and (S)-2-ethyl-hexyl acetate (55%, 75:25 e:r). 2-ethyl-1-hexanol: FTIR: 3337, 2958, 
2928, 2869, 1462, and 1041 cm-1. 1H NMR (60 MHz): δ=0.73-1.42 ppm, m, 16H, Me, Et and OH 
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protons; 3.54 ppm, d, 2H, HO-Et protons. m/z: 29, 41, 57, 70, 83, 98, 112. 2-ethylhexyl acetate: 
FTIR: 2959, 1743, 1644, 1037 cm-1. 1H NMR (60 MHz): δ=0.77-1.59 ppm, m, 15 H, Me and Et 
protons; 2.01 ppm, s, 3 H, Ac-Me H; 3.91-3.99 ppm, d, 2H, HO-Et protons. m/z: 29, 43, 57, 70, 
83, 112. 
Hydrolysis of 2-ethylhexyl acetate: 2-ethylhexyl acetate was then combined with aqueous 
potassium hydroxide (5.93 M, 2 eq) in absolute ethanol (to 0.33 M acetate) and stirred at room 
temperature for 30 minutes. The reaction mixture was tested by thin layer chromatography (9:1 
hexanes/ethyl acetate and visualized with CAM). Once deemed complete by TLC, the reaction 
was then acidified with hydrochloric acid (50 mL, 1 M) and diluted with deionized water (100 mL) 
to form a cloudy solution. The mixture was then extracted with four 20 mL portions of ether. The 
ether layers were then combined, washed with brine, and dried with magnesium sulfate. The 
solution was then evaporated under reduced pressure to yield (S) enriched 2-ethyl-1-hexanol 
(82% yield, 75:25 e.r.)  
Further purification of (S)-2-ethyl-1-hexanol: The acylation and hydrolysis procedures detailed 
above were run a second time, scaling down for the small amount of (S)-2-ethyl-1-hexanol. 
(39% yield, 91:9 e.r.) 
Synthesis of MEHP: 2-ethyl-1-hexanol (0.26 g, 2 mmol) and phthalic anhydride (0.30 g, 2mmol, 
1 eq) were combined in 1:3 pyridine/benzene (0.8 mL, to 2.5 M) The mixture was stirred at 
100oC for 2 hours, then quenched with  hydrochloric acid (1 M, 10 mL). The heterogeneous 
mixture was then extracted with three 10 mL portions of dichloromethane, washed with 10 mL 
brine, and dried with magnesium sulfate. The solution was then evaporated under reduced 
pressure to yield the crude product. Various purification methods were attempted and detailed in 
the Results and Discussion section. FTIR: 3075, 2960, 2931, 2873, 1702, 1600, 1581, 1290, 
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1075 cm-1. 1H NMR: δ=0.82-1.47 ppm, m, 17 H, Me and Et H; 4.17-4.25 ppm, d, 2H, COOR-Et 
H; 7.60-7.94 ppm, 4H, Ar-H; 10.36 ppm, s, COO-H. m/z: 29, 41, 43, 57, 70, 83, 149, 167. 
Synthesis of DEHP: 2-ethyl-1-hexanol (0.12 g, 0.91 mmol) was combined with MEHP (0.28 g, 1 
mmol, 1.1 eq), diisopropylcarbodiimide (0.14 g, 1.1 mmol, 1.2 eq), and 4-dimethylaminopyridine 
(0.0022 g, 0.02 mmol, 0.002 eq) in dichloromethane (5.2 mL, 0.2 M alcohol). The mixture was 
stirred at room temperature for 19 hours. The cloudy mixture was diluted with 25 mL 
dichloromethane, filtered over Celite, and then evaporated under reduced pressure. The crude 
product was then purified via flash chromatography in a hexanes/ethyl acetate gradient (2-20% 
ethyl acetate). The fractions were tested via thin layer chromatography (1:1 ethyl 
acetate/hexanes, stained with CAM). The fractions were then combined and evaporated under 
reduced pressure to yield DEHP (39% yield) FTIR: 2959, 2931, 2867, 1730, 1462, 1279, and 
1126 cm-1. NMR (60 MHz): δ=0.80-1.59 ppm, m, 32 H, Me, Et and OH protons; 4.26-4.17 ppm, 
d, 4H, Et H; 7,42-7.80 ppm, 4 H, Ar-H. m/z: 29, 43, 57, 71, 83, 149, 167, 279, 391.  
Gas Chromatography Mass Spectroscopy: MEHP and DEHP were analyzed on a Shimadzu 
GC-2010plus equipped with a QP2010SE MS with a Shimadzu SH-Rxi-5Sil column and the 
following method: ramp from 40oC to 300oC at 20.00oC/min with a 5 minute hold at 300oC. The 
injector and interface temperatures were 300oC, and the ion source temperature was 200oC. 
The 1 μL injection was split 20.00:1, with a pressure of 91.5 kPa , linear velocity of 46.1 cm/s, 
and helium as the carrier gas. The MS scanned from m/z 25-400 with a scan speed of 1428 
three minutes after injection.  
Chiral Gas Chromatography Flame Ionization Detection: 2-ethyl-1-hexanol and 2-ethylhexyl 
acetate were analyzed on an Agilent 7820A GC-FID with a Restek βdex SA or SE column 
according to the following method: ramp from 50oC to 180oC at 1oC/min, no hold, with an 
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injector temperature of 230oC. The 1 μL injection was split 50:1 with a pressure of 10.621 psi, 
linear velocity of 37 cm/s, and helium as the carrier gas. 
  
  19 
Results and Discussion 
Optimization of Acylation 
 In order to determine the optimum conditions and catalyst best suited to resolve the 
enantiomers of 2-ethyl-1-hexanol, the lipase, temperature, and solvent were varied. Vinyl 
acetate was used as the acyl donor in all reactions based upon previous research by Chantal et 
al.,24 as well as similar enzymes to those used by the researchers. Lipase from Pseudomonas 
flourescens (PLF) was first tested with 3.5 mg lipase per mmol 2-ethyl-1-hexanol at room 
temperature for 72 hours in THF. These conditions proved too reactive, with only 2-ethylhexyl 
acetate isolated after purification by column chromatography.  To try and improve the 
stereoselectivity of PLF, the temperature was lowered to 0oC. Though some alcohol was 
isolated, PLF was still deemed too reactive for effective separation, as the majority was reacted 
to form acetate. 
 Lipase from porcine pancreas (PPL) was then tested at 15 mg per mmol alcohol and 00C 
for 24 hours in dichloromethane. The enzyme loading was increased relative to PLF based on 
previous research,24 which had found PPL to be less reactive compared to PLF. Unlike PLF, 
there was a fairly even split of 2-ethyl-1-hexanol and 2-ethylhexyl acetate, with 2 mmol of both 
the acetate and alcohol isolated after workup. To test the selectivity of PPL, the reaction was 
monitored by GC-FID equipped with a chiral column able to separate the enantiomers of 2-
ethyl-hexanol. The enantiomeric ratio and acetate yield over time of PPL is shown below in 
Figures 1 and 2. 
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Figure 1: Plot of percent (R)-2-ethyl-1-hexanol versus time for PPL. The 
enantiomeric ratio stays around 50% for the duration of the reaction, 
meaning that PPL shows no preference between the enantiomers of 2-ethyl-
1-hexanol. 
Figure 2: Plot of acetate yield (100∙AAc/(A(R)+A(S)+AAc)) versus time for PPL. 
Yields for this reaction remain low, with under 20% for most of the reaction, 
and only 48% after 72 hours. 
  21 
 It should be noted that the acetate yield was calculated using uncorrected peak areas. 
This causes no error for the two enantiomers of 2-ethyl-1-hexanol, as they have the same 
response factor towards the flame detector. However, it is very likely that 2-ethylhexyl acetate 
has a different response factor than 2-ethyl-1-hexanol. Some experiments were attempted with 
an inert internal standard added to the reaction mixture which would allow for quantitation and 
response factor determination. However, evaporation of both solvent and the internal standard 
over the 48 hour reaction time prevented quantitative analysis of the reactants. Though there is 
almost certainly a response factor difference between the two compounds, the difference is 
likely small due to their structural similarity. 
 This being said, the kinetic study still indicates that PPL was unsuitable for resolving 2-
ethyl-1-hexanol. The enantiomeric ratio of the unreacted alcohol did not change significantly 
from 50%, meaning that the lipase was reacting (R) and (S)-2-ethyl-1-hexanol in equal 
proportions. This renders PPL useless for kinetic resolution due to a lack of stereoselectivity 
toward 2-ethyl-1-hexanol. 
 Finally, lipase from the bacterium Burkholderia cepacia (PSBC) was tested. As for PPL, 
a kinetic study was performed to determine the stereoselectivity of PSBC toward 2-ethyl-1-
hexanol. PSBC was loaded with 15 mg per mmol of 2-ethyl-1-hexanol and reacted in 
dichloromethane at 0oC. Like PPL, the enzyme loading of PSBC was increased compared to 
PLF due to lower reactivity of PSBC, requiring higher catalyst concentrations to achieve 
conversion in roughly the same reaction times. From this study, the enantiomeric ratio and yield 
versus time, as well as the enantiomeric ratio of versus yield were determined. These are 
plotted below in Figures 3, 4 and 5.  
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Figure 3: Plot of percent (R)-2-ethyl-1-hexanol versus time for PSBC. Unlike 
PPL, this enzyme showed an increase in enantiomeric ratio versus time, with 
the enzyme approaching nearly pure (R) alcohol after 48 hours. 
 
Figure 4: Plot of percent acetate yield (100∙AAc/(A(R)+A(S)+AAc)) versus time for 
PSBC. At 48 hours, the yield of acetate is over 70%, meaning that some of 
the (R) alcohol is reacting in addition to the (S). 
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 PSBC showed significant selectivity for (S)-2-ethyl-1-hexanol. At 48 hours, the unreacted 
(R) alcohol was nearly completely pure, with enantiomeric purity approaching 100%. 
Unfortunately, the acetate yield after about 12 hours was greater than 50%, with a yield of 75% 
at 48 hours. If PSBC were perfectly stereoselective, an acetate yield of 50% would be the 
highest observed. Above 50%, the enzyme is also reacting some proportion of both 
enantiomers. Indeed, it was found that (S)-2-ethyl-1-hexanol sample was only 68% 
enantiomerically pure, indicating that a significant portion of (R)-2-ethyl-1-hexanol was also 
acylated as well. However, the ability to isolate nearly pure (R)-2-ethyl-1-hexanol in a single 
reaction is valuable. Moreover, 2-ethyl-1-hexanol and 2-ethyl-1-hexyl acetate were easily 
separated by column chromatography, with Rf’s of 0.11 and 0.41, respectively in 9:1 
hexanes/ethyl acetate. Subsequent acylations typically resolved (R)-2-ethyl-1-hexanol in 94-
96% enantiomeric purity, while (S)-2-ethylhexyl acetate had an enantiomeric purity of 70-75%. 
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Figure 5: Plot of enantiomeric percent versus percent acetate yield 
(100∙AAc/(A(R)+A(S)+AAc)) for PSBC. A fairly linear trend of ER versus acetate 
yield is observed, meaning that 48 hours is near or at the optimum reaction 
time for this enzyme. 
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The absolute configuration of the resolved enantiomers was determined by comparison with 
Chantal et al.27 
 To recover the (S) enriched samples of 2-ethyl-1-hexanol, the acetate group was 
hydrolyzed using potassium hydroxide in both absolute ethanol and methanol. The reaction 
proved easy and recovered the (S)-alcohol in relatively high yields. Only two equivalents of base 
and 30 minutes of reaction time at room temperature were required, and the (S)-alcohol was 
typically isolated in 80-90% yield. Moreover, the choice of solvent did not have an appreciable 
effect on (S)-2-ethyl-1-hexanol recovery. The (S) enriched alcohol was not enantiomerically 
pure enough to use in synthesizing the stereoisomers of MEHP and DEHP. However, a second 
round of acylation followed by hydrolysis could be easily used to further purify the (S)-alcohol. 
After acylating and hydrolyzing a second time, (S)-2-ethyl-1-hexanol was isolated in 91% yield. 
Though not as enantiomerically pure as the (R) alcohol or as pure as desired, these samples 
could still be used to synthesize MEHP and DEHP. 
From these experiments, a scheme to resolve the two enantiomers of 2-ethyl-1-hexanol was 
developed and is outlined in Scheme 6. 
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 It should be noted that during acylation, an unexpected product was observed via TLC 
with an Rf higher than 2-ethylhexyl acetate and considerable streaking. At first, this product was 
assumed to be unreacted vinyl acetate and was mostly ignored. Moreover, the product was not 
present after hydrolysis and was deemed unimportant in the resolution scheme. However, GC-
MS analysis of 2-ethylhexyl acetate revealed a second peak with a significantly longer retention 
time and similar area to 2-ethylhexyl acetate. This peak had an M+ peak of 271 and was 
identified by a similarity search as 1,1’-[ethylidenebis(oxy)]bisoctane. Because n-octyl and 2-
ethyl-1-hexyl substituents would likely have similar mass fragmentation patterns, this product is 
likely 1,1’-[ethylidenebis(oxy)]bis(2-ethyl)hexane, shown below in Figure 6. 
Scheme 6: Resolution scheme for 2-ethyl-1-hexanol, with the (R) enriched alcohol recovered as the 
unreacted starting material during the first round of acylation, and two rounds of acylation and 
hydrolysis to recover the (S)-enriched alcohol. 
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 How this product formed is not entirely clear. During the enzymatic reaction, the acyl 
group of vinyl acetate is transferred to 2-ethyl-1-hexanol, forming 2-ethylhexyl acetate and vinyl 
alcohol. This vinyl alcohol quickly tautomerizes to acetaldehyde. The most likely explanation is 
that two equivalents of 2-ethyl-1-hexanol reacts with acetaldehyde to form the acetal 1,1’-
[ethylidenebis(oxy)]bis(2-ethyl)hexane (Scheme 7). More importantly, how this side product 
affects the enantiomeric purity of the products is also not known. Further work is needed to 
purify and characterize this side product as well as the enatiomeric purity of any 2-ethyl-1-
hexanol recovered from it. 
 
 
 Despite this unexpected result, the scheme outlined in Scheme 6 was used to resolve 
larger amounts of 2-ethyl-1-hexanol. Scaling up the reaction was fairly straightforward, with all 
reagents scaled in the same proportions. Some difficulty was had in producing sufficient 
Figure 6: Structure of 1,1’-[ethylidenebis(oxy)]bis(2-ethyl)hexane, the acetal 
of acetaldehyde and 2-ethyl-1-hexanol. 
Scheme 7: Formation of acetaldehyde during acylation of 2-ethyl-1-hexanol, and the reaction of 
acetaldehyde with 2-ethyl-1-hexahol to form 1,1’-[ethylidenebis(oxy)]bis(2-ethyl)hexane. 
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amounts of each enantiomer due to losses at each step but could be overcome by increasing 
the initial amount of 2-ethyl-1-hexanol used in the first acylation. 
Synthesis of MEHP and DEHP 
 Using the enantiomerically pure samples of 2-ethyl-1-hexanol, the two enantiomers of 
MEHP were synthesized by combining one equivalent of 2-ethyl-1-hexanol with one equivalent 
of phthalic anhydride. Though this reaction was fairly facile, an unexpected challenge arose in 
purifying MEHP from the two starting materials. GC-MS analysis of the reaction mixture showed 
that the two starting materials were still present after purification by flash chromatography. 
Separation of the unreacted 2-ethyl-1-hexanol was important in the subsequent reaction to form 
DEHP, as another equivalent of 2-ethyl-1-hexanol was added to MEHP in an esterification 
reaction. Any unreacted alcohol from the previous step would have decreased the enantiomeric 
purity of the resulting DEHP. In addition, this impurity would hamper effective biological testing, 
as there would be uncertainty as to whether any biological effects are due to MEHP or the 
unreacted 2-ethyl-1-hexanol. Testing by thin layer chromatography revealed that 2-ethyl-1-
hexanol and MEHP had very similar Rf’s, precluding purification by column chromatography. 
Numerous solvent systems were tested in an attempt to improve separation, among them ethyl 
acetate/hexanes, dichloromethane/acetone, dichloromethane/methanol, and chloroform/ethyl 
acetate. Streaking caused by the carboxylic acid group in MEHP exacerbated the R f similarity, 
making separation impossible. Though addition of 0.5% acetic acid to all of the solvent systems 
mentioned above did reduce streaking significantly and allow separation of phthalic anhydride in 
certain cases, it still did not allow for effective separation of 2-ethyl-1-hexanol and MEHP. 
 In addition to chromatography, a chemically active extraction was attempted to exploit 
the carboxylic acid present in MEHP. The reaction mixture was first dissolved in 20 mL ether, 
then extracted with 20 mL water treated with 10% (w/v) potassium carbonate until strongly 
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alkaline (pH 8-9). The aqueous layer was then separated, acidified, and extracted with a fresh 
portion of ether (20 mL). Ideally, the first extraction should have deprotonated MEHP and 
caused the negatively charged species to transfer to the aqueous layer. Alcohols have pKa’s 
several orders of magnitude larger than carboxylic acids, meaning that 2-ethyl-1-hexanol should 
not have been deprotonated and remained in the first ether layer. In the second extraction, 
MEHP should have been protonated again to form a neutral species and transfer to the new 
portion of ether. Unfortunately, analysis by GC-MS and TLC revealed that MEHP and 2-ethyl-1-
hexanol were present in both ether layers, meaning that even when deprotonated, MEHP did 
not have a very large preference for the aqueous layer. The presence of 2-ethyl-1-hexanol in 
the second ether portion was likely due to basic hydrolysis of the ester bond between the 
phthalate and 2-ethyl-1-hexanol moieties.  
 Vacuum distillation was also attempted to try and separate MEHP and the unreacted 
alcohol. 2-ethyl-1-hexanol has a boiling point of 186.2oC, while MEHP boils at a temperature 
greater than 300oC.27 This difference in boiling point should have been high enough to allow 
easy separation by vacuum distillation using a Kugelrohr apparatus. Unfortunately, 2-ethyl-1-
hexanol was also present in the sample after the attempted purification. It is unclear whether 2-
ethyl-1-hexanol is actually present in the sample, or if it an artifact of GC-MS analysis. Because 
MEHP has a high boiling point, an inlet temperature of 300oC was used to move the sample 
onto the column. One possibility is that MEHP was degrading in the inlet into 2-ethyl-1-hexanol 
and phthalic anhydride. To test for this, the inlet temperature was lowered to 200oC. It was 
found that a significantly lower amount of both 2-ethyl-1-hexanol and phthalic anhydride were 
detected by the GC-MS, indicating that the high temperature of the inlet was responsible for 
some degradation. Moreover, comparing retention times with pure samples of the starting 
material rules out degradation on the column itself, as the retention times are exactly the same. 
If degradation were occurring on the column, one would observe broad, poorly resolved peaks 
  29 
with retention times different than the pure materials. However, the extent of degradation is 
unclear, and it is still possible that some of the starting material is present in the MEHP sample. 
Compounding this problem is that the instrument response factors for MEHP, 2-ethyl-1-hexanol, 
and phthalic anhydride are also unknown. Without a way to purify MEHP and unambiguously 
determine its purity, the stereoisomers of DEHP cannot be synthesized with reliability. 
 Before the issues in purity had been fully realized, impure samples of (R)-MEHP were 
used to synthesize (R,R)-DEHP and (R,S)-DEHP from (R)-MEHP and an equivalent of either 
(S) or (R)-2-ethyl-1-hexanol. This was accomplished through the reaction of MEHP with 
stoichiometric quantities of diisopropylcarbodiimide (DIC) and catalytic amounts of 4-
dimethylaminopyridine (4-DMAP). This reaction proved straightforward, with DEHP formed in 
decent yields and isolated easily from the starting materials. Though the MEHP reaction has 
proved problematic, the subsequent reaction to form DEHP will be no barrier to synthesizing the 
three different stereoisomers. One issue of note is that the enantiomeric purity of MEHP and 
DEHP could not be determined using the chiral GC column used to analyze 2-ethyl-1-hexanol 
and 2-ethylhexyl acetate. The chiral columns used had maximum set temperature of 180oC. 
Unfortunately, this temperature was too low for MEHP and DEHP to move on the column. 
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Conclusion 
 An effective resolution scheme for the enantiomers of 2-ethyl-1-hexanol was developed 
using lipase from Burkholderia cepacia, with the solvent and reaction time optimized. (R)-2-
ethyl-1-hexanol was isolated in 95% or greater enantiomeric purity as the unreacted alcohol in 
the first acylation, and (S)-2-ethyl-1-hexanol was isolated in 91% enantiomeric purity after two 
acylation/hydrolysis reactions. However, further optimization could be still pursued. One of the 
main drawbacks to this method is that a total of four reactions are required to isolate pure (S)-2-
ethyl-1-hexanol, resulting in considerable loss during resolution. The ability to resolve 2-ethyl-2-
hexanol in one step would be ideal, as well as higher enantiomeric purity of the resolved 
enantiomers. In addition, the formation of the acetal 1,1’-[ethylidenebis(oxy)]bis(2-ethyl)hexane 
is a major issue, as its co-elution with 2-ethylhexyl acetate almost certainly impacts the 
enantiomeric purity of the resulting (S)-2-ethyl-1-hexanol upon hydrolysis. Several different 
avenues could be used to address these issues. One possibility is to use isopropenyl acetate as 
the acyl donor rather than vinyl acetate. Acyl transfer and tautomerization of isopropenyl acetate 
will produce acetone rather than acetaldehyde. Because acetal formation is slower for ketones 
than aldehydes, it would likely decrease the amount of acetal formed during the reaction. In 
addition, the change in acyl donor may result in an increase in stereoselectivity towards 2-ethyl-
1-hexanol. A second way to improve the stereoselectivity of the acylation reaction would be to 
test different reaction conditions. The temperatures and solvents used were based mostly on 
the work of Chantal et al. without much modification.27 A more thorough survey of different 
solvents could be done, as well as decreasing the temperature of the reaction. Kinetic resolution 
relies on a difference in activation energy between the two enantiomers of a compound in a 
reaction. By lowering the temperature, fewer molecules have sufficient energy to overcome the 
higher activation barrier, leading to a better resolution of the enantiomers. Though the reaction 
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would likely take longer due to the lower temperature, the gain in enantiomeric purity would be 
valuable. 
 The reaction of 2-ethyl-1-hexanol with phthalic anhydride to form MEHP was successful, 
though the need to ensure purity of the product is still an outstanding problem. More specifically, 
determining to what extent MEHP is degrading during GC-MS analysis is paramount. 
Derivatization reactions could be used to remove the carboxylic group from MEHP, which would 
allow for lower inlet and oven temperatures to analyze. This in turn would hopefully eliminate 
any degradation during analysis. Secondly, an internal standard could be used to determine the 
response of 2-ethyl-1-hexanol, phthalic anhydride, and the MEHP derivative. From this, the 
actual concentrations of each compound in the reaction mixture could be determined. 
Alternatively, LC-MS could be used to bypass degradation entirely. LC-MS is better suited for 
higher molecular weight compounds which are not volatile enough for easy GC-MS analysis, as 
the ambient temperatures used during LC-MS analysis would eliminate any degradation 
occurring. Once operational, the LC-MS may be the best option for analyzing MEHP. Moreover, 
if equipped with a chiral column, it would allow for direct measurement of enantiomeric purity of 
MEHP and DEHP. 
 If analysis reveals that MEHP is still impure, the problem of purification once more will 
come to the forefront. Numerous solvent systems were used in an attempt to purify MEHP. 
Though other solvent systems could be tested, nearly all common TLC solvent systems have 
been exhausted. A chemically active extraction proved ineffective as well, with basic conditions 
causing hydrolysis of the ester bond between the phthalate and 2-ethyl-1-hexyl moieties. 
Vacuum distillation holds the most promise, despite it initially not succeeding. A relatively low 
temperature of 60oC was used to try and distill 2-ethyl-1-hexanol. Though this proved sufficient 
to distill pure 2-ethyl-1-hexanol, it proved insufficient in the reaction mixture. Higher 
temperatures were not attempted for fear of degrading MEHP. If MEHP proves stable at higher 
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temperatures, the reaction mixture could be purified by vacuum distillation alone; separating 
phthalic anhydride (a solid), 2-ethyl-1-hexanol (b.p.186.2oC) and MEHP (b.p. above 300oC).27 
 Luckily, the reaction of MEHP with 2-ethyl-1-hexanol to form DEHP is fairly 
straightforward, with easy chromatographic separation of the starting materials from the product. 
Once purification of MEHP has been accomplished, the synthesis of the different stereoisomers 
of DEHP should be fairly simple. In addition, the resolution scheme, MEHP and DEHP reactions 
should be applicable to other alcohols, such as 2-allyl-1-hexanol, to form the chiral samples of 
the different metabolites of DEHP. 
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Appendix 
Materials 
Chemical Purity/Grade Distributor 
Lipase from Burkholderia 
cepacia 
≥30,000 U/g Sigma-Aldrich 
Lipase from Porcine Pancreas  100-400 U/mg Sigma-Aldrich 
Lipase from pseudomonas 
fluorescens 
≥20,000 U/g Sigma-Aldrich 
Vinyl acetate 99+%, stabilized Acros 
2-ethyl-1-hexanol - J.T. Baker Chemical Co. 
Potassium hydroxide ACS ceritifed Fisher 
Phthalic anhydride 99% Acros Organics 
Diisopropylcarbodiimide 99% Acros Organics 
4-dimethylaminopyridine 99% Acros Organics 
Dichloromethane HPLC grade Fisher 
Ethyl acetate HPLC grade Fisher 
Hexanes HPLC grade Fisher 
Methanol HPLC grade Fisher 
Ethanol Absolute, ACS grade Pharmco-AAPER 
 
List of Abbreviations 
DEHP: di(2-ethylhexyl) phthalate 
MEHP: mono(2-ethylhexyl) phthalate 
PLF: Lipase from the species Pseudomonas fluorescens 
PPL: Lipase from porcine pancreas 
PSBC: Lipase from Burkholderia cepacia 
NMR: Nuclear magnetic resonance spectroscopy 
IR: infrared spectroscopy 
GC-FID: Gas chromatography flame ionization detection 
GC-MS: Gas chromatography mass spectrometry 
LC-MS: Liquid chromatography mass spectrometry 
TLC: thin layer chromatography 
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NMR spectrum of 2-ethyl-1-hexanol 
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IR spectrum of 2-ethyl-1-hexanol 
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GC-MS chromatogram and mass spectrum of 2-ethyl-1-hexanol 
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Chiral GC-FID chromatogram of racemic 2-ethyl-1-hexanol 
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NMR spectrum of 2-ethylhexyl acetate 
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IR spectrum of 2-ethylhexyl acetate 
 
 
  43 
 
GC-MS chromatogram and mass spectrum of 2-ethylhexyl acetate 
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Chiral GC-FID Chromatogram of 2-ethylhexyl acetate after first the first acylation with PSBC 
  
  45 
GC-MS Chromatogram of 1,1’-[ethylidenebis(oxy)bis(2-ethyl)hexane 
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NMR spectrum of mono(2-ethylhexyl)phthalate 
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IR spectrum of mono(2-ethylhexyl)phthalate 
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GC-MS chromatogram and mass spectrum of mono(2-ethylhexyl)phthalate 
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NMR spectrum of di(2-ethylhexyl)phthalate 
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IR spectrum of di(2-ethylhexyl)phthalate 
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GC-MS chromatogram and mass spectrum of di(2-ethylhexyl)phthalate 
 
